专利检索 ap:("NOVARTIS AG") AND inv:"Margaret DUGAN" 第 1 页

1.

发明申请
USE OF IL-1beta BINDING ANTIBODIES 审中-公开

公开(公告)号：US20190048072A1

公开(公告)日：2019-02-14

申请号：US15970542

申请日：2018-05-03

申请人： Novartis AG

发明人： Monica Ligueros-Saylan , Patrice Matchaba , Tom Thuren , Paul Ridker , Peter Libby , Penelope OTTEWELL , Yi Yang LAU , Margaret DUGAN

IPC分类号： C07K16/24 , A61P35/00 , G01N33/574 , A61K9/00

摘要： Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.

2.

发明公开
IL-1BETA BINDING ANTIBODIES FOR USE IN TREATING CANCER 审中-公开

公开(公告)号：US20230220063A1

公开(公告)日：2023-07-13

申请号：US16624130

申请日：2018-06-22

申请人： NOVARTIS AG

发明人： Monica LIGUEROS-SAYLAN , Patrice MATCHABA , Tom THUREN , Paul RIDKER , Peter LIBBY , Penelope OTTEWELL , Yang Yi LAU , Margaret DUGAN

IPC分类号： C07K16/24 , A61K39/00 , A61P35/00 , A61K9/00 , G01N33/574

CPC分类号： C07K16/245 , A61K9/0019 , A61K39/00114 , A61P35/00 , G01N33/57423 , A61K31/282 , A61K2039/54 , A61K2039/82 , A61K2039/86 , A61K2039/505 , A61K2039/545 , A61K2039/828 , A61K2039/836 , A61K2039/868

摘要： Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.